Abstract | OBJECTIVE: METHODS: RESULTS: The serum level of MMP-2 in breast cancer was significantly higher than that in breast fibroadenoma (12.24 vs 2.21 µg/L, P = 0.003). Subgroup analysis showed that the serum levels of MMP-2 were higher in HER-2 positive patients than those in HER-2 negative ones (16.77 vs 10.02 µg/L, P = 0.022). CK19 mRNA was found in blood samples from 30 cases of breast cancer and the positive rate was 41.7%. However, it was not detected in the patients with breast fibroadenoma. The mean levels of serum MMP-2 were (15.48 ± 2.02) and (7.16 ± 1.55) µg/L in CK19 positive and negative patients respectively. Significant difference existed between two groups (P = 0.013). CONCLUSION:
|
Authors | Ju-liang Zhang, Qing Yao, Jiang-hao Chen, Ting Wang, Hui Wang, Jing Fan, Ling Wang |
Journal | Zhonghua yi xue za zhi
(Zhonghua Yi Xue Za Zhi)
Vol. 92
Issue 16
Pg. 1104-6
(Apr 24 2012)
ISSN: 0376-2491 [Print] China |
PMID | 22781768
(Publication Type: English Abstract, Journal Article, Research Support, U.S. Gov't, Non-P.H.S.)
|
Chemical References |
- Keratin-19
- MMP2 protein, human
- Matrix Metalloproteinase 2
|
Topics |
- Adult
- Breast Neoplasms
(blood, pathology)
- Female
- Humans
- Keratin-19
(blood)
- Matrix Metalloproteinase 2
(blood)
- Middle Aged
- Neoplasm Micrometastasis
- Neoplastic Cells, Circulating
|